Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03772977 · ClinicalTrials.gov registry record · NA

The Brain Health Champion Study

A NA study of Mild Cognitive Impairment and Dementia, Mild, sponsored by Brigham and Women's Hospital.

Active
Registry status
NA
Development phase
95
Enrollment target
1
Study location

NCT03772977: Active NA study of Mild Cognitive Impairment and Dementia, Mild, sponsored by Brigham and Women's Hospital.

NCT03772977 is a NA study of Mild Cognitive Impairment and Dementia, Mild that is active but no longer recruiting, run by Brigham and Women's Hospital. The registered enrollment target is 95 participants, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03772977, a NA study of Mild Cognitive Impairment and Dementia, Mild, is active but no longer recruiting, sponsored by Brigham and Women's Hospital.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
95 participants
Enrollment target
1
Study location

Study Summary

6-month, randomized, controlled investigation measuring the effect of increased clinical contact and personalization compared to standard physician counseling on adherence to consensus-based, brain health recommendations for patients with subjective cognitive decline, mild cognitive impairment, and early dementia or patients who are at risk for developing these conditions.

Primary Outcome

Goulet Mediterranean Diet Score (questionnaire). Measured adherence to the Mediterranean Diet. Likert Scale 0-44, with higher values indicating stronger adherence to the dietary pattern.

Conditions Studied

Mild Cognitive Impairment Dementia, Mild Subjective Cognitive Decline At Risk for Cognitive Decline

Interventions

  • BEHAVIORAL Brain Health Champion

Study Locations (1)

Massachusetts

  • Brigham and Women's Hospital, Department of Neurology - Boston

Trial Details

FieldValue
Enrollment Target 95 participants
Start Date 2017-05-08
Est. Completion 2026-06-01
Phase NA
Brigham and Women's Hospital

937 total trials

What the registry record for NCT03772977 still lists

NCT03772977 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 95 participants, a relatively small participant target, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (93% lower).

The record links to 4 conditions, with Mild Cognitive Impairment appearing as the primary indexed condition, and to 1 intervention - of which Brain Health Champion is the first listed.

NCT03772977 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03772977 about?

NCT03772977 is a clinical study titled "The Brain Health Champion Study". 6-month, randomized, controlled investigation measuring the effect of increased clinical contact and personalization compared to standard physician counseling on adherence to consensus-based, brain health recommendations for patients with subjective cognitive decline, mild cognitive impairment, and ...

What is the current status of trial NCT03772977?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 95 participants. The study started on 2017-05-08. Estimated completion is 2026-06-01.

What conditions does trial NCT03772977 study?

This clinical trial studies the following conditions: Mild Cognitive Impairment, Dementia, Mild, Subjective Cognitive Decline, At Risk for Cognitive Decline.

What interventions are being tested in trial NCT03772977?

The interventions under investigation include: Brain Health Champion (BEHAVIORAL).

Who is sponsoring clinical trial NCT03772977?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03772977 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Mild Cognitive Impairment

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03772977's enrollment target sits among peer trials

95 94th of 205 higher than 112 of 205 other Mild Cognitive Impairment trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Mild Cognitive Impairment trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03339128 · 95 participants · Phase 2

    Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children

  • NCT03509961 · 95 participants · Phase 2

    The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

  • NCT03694756 · 95 participants · NA

    TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer

  • NCT04206215 · 95 participants · NA

    Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT03772977, the US trial registry maintained by the National Library of Medicine. NCT03772977 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.